{
  "report_rows": [
    {
      "kpi": "EPS - Diluted - Operating",
      "prediction": "BEAT",
      "answer": "pred ~$0.20 vs. cons $0.1618",
      "confidence": "HIGH"
    },
    {
      "kpi": "EBITDA - Operating",
      "prediction": "MISS",
      "answer": "pred ~$800M vs. cons $832M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operation and Maintenance",
      "prediction": "BEAT",
      "answer": "pred ~$405M vs. cons $422M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 EPS (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.045 mid vs. cons $2.052",
      "confidence": "HIGH"
    },
    {
      "kpi": "GenCo Commentary (qualitative, FY 2026)",
      "prediction": "BETTER",
      "answer": "IURC approval confirmed, Alphabet service beginning, pipeline progress on 3GW",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 0.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.5,
  "day5_path": "STABILIZE",
  "day5_rationale": "STABILIZE \u2014 implied H2 cut limits follow-through; GenCo floor prevents full fade",
  "day5_confidence": "MEDIUM"
}